DEA Records, Harold Nelson Bornstein (1947 - 2021)

T. McElwee filed this request with the Drug Enforcement Administration of the United States of America.
Tracking #

21-00197-F

Due Feb. 12, 2021
Est. Completion None
Status
Awaiting Response

Communications

From: T. McElwee


To Whom It May Concern:

Pursuant to the Freedom of Information Act, I hereby request the following records:

All DEA records mentioning or pertaining to the late Harold Nelson Bornstein, private physician. An attached obituary shall serve as proof Bornstein has passed away in 2021; as such, privacy interests recognized under exemptions to FOIA as well as the Privacy Act are diminished, and investigations concerning Bornstein as a subject are minimally impacted.

To assist in the identification of records, please note the following identifiers:

First five digits of Social Security Number 078-38;
DOB: March 3, 1947;
POB: New York, NY.

"DEA Records" include records within the following systems of records (not exclusively): Automated Intelligence Records System (Pathfinder); Investigative Reporting and Filing System (IRFS); Grants of Confidentiality Files (GCF); Operations Files; Automated Records and Consolidated Orders System- Diversion Analysis and Detection System (ARCOS-DADS); Controlled Substances Act Registration Records (CSA); Registration Status-Investigation Records; and Security Files.

In addition, please return a result for a query of Narcotics and Dangerous Drugs Information System (NADDIS) pointer index to IRFS, using the aforementioned subject's name and (where necessary) accompanying identifying numbers and/or date of birth.

If any potentially responsive records have been destroyed and/or transferred to NARA, then I request copies of the destruction or transfer slips as well as any other documentation relating to, mentioning or describing said transfer or destruction, to include but not be limited to confirmation that the Bureau has no other copies of said records.

The requested documents will be made available to the general public, and this request is not being made for commercial purposes.

In the event that there are fees, I would be grateful if you would inform me of the total charges in advance of fulfilling my request. I would prefer the request filled electronically, by e-mail attachment if available or CD-ROM if not.

Thank you in advance for your anticipated cooperation in this matter. I look forward to receiving your response to this request within 20 business days, as the statute requires.

Sincerely,

T. McElwee

  • Harold20N.20Bornstein2C20TrumpE28099s20Former20Personal20Physician2C20Dies20at2073.pdf

From: Drug Enforcement Administration

Subject: DEA FOIA Case Number 21-00197-F

Good morning Mr. McElwee,

This is to acknowledge receipt of your Freedom of Information Act/PA (FOIA) request by the Drug Enforcement Administration, FOIA Section. This response is a courtesy reply. It does not replace the acknowledgement letter that will be sent to you once your request has been reviewed by our Intake Unit. Please note, requests are handled in the order they are received. We will advise you if any additional information is required.

Please be advised, due to necessary operational changes as a result of the national emergency concerning the novel coronavirus disease (COVID-19) outbreak, there may be some delay in the processing of your request.

You may wish to visit DEA's public facing website at www.dea.gov<http://www.dea.gov> or the FOIA Library available at https://www.dea.gov/divisions/dea-foia-library to determine if the information you seek is already available to the public.

You may contact our FOIA Public Liaison at (571) 776-3139 for any further assistance and to discuss any aspect of your request. Additionally, you may contact the Office of Government Information Services (OGIS) at the National Archives and Records Administration to inquire about the FOIA mediation services they offer. The contact information for OGIS is as follows: Office of Government Information Services, National Archives and Records Administration, Room 2510, 8601 Adelphi Road, College Park, Maryland 20740-6001; e-mail at ogis@nara.gov<mailto:ogis@nara.gov>; telephone at (202) 741-5770; toll free at 1-877-684-6448; or facsimile at (202) 741-5769.

If you have any questions regarding this email, you may contact our FOIA Requester Service Center at (571) 776-2300. Thank you for your patience as we work to complete the processing of your request.

Sincerely,

Tonia Woodley
IBSS Corp. Paralegal III (Contractor)
Initial Review Team
Freedom of Information/Privacy Act Section (FSR)
U.S. Drug Enforcement Administration
Email: Tonia.Woodley@usdoj.gov<mailto:Tonia.Woodley@usdoj.gov>
Phone: 571-776-3704

PRIVACY ACT NOTICE: This e-mail (including any attachments herein) may contain personal and privileged information that requires protection in compliance with the Privacy Act of 1974 (5 U.S.C. § 552a). Any use of this information by anyone other than the intended recipient is prohibited. If you have received this communication in error, please immediately delete all copies of this information and notify me by e-mail. The use, dissemination, distribution, or reproduction of this communication by unintended recipients in not authorized and may be unlawful.

From: Drug Enforcement Administration

Good Morning Mr. McElwee,

We are in receipt of your recent inquiry regarding the status of your pending Freedom of Information/Privacy Act request. Please be advised that due to the national emergency concerning the novel coronavirus disease (COVID-19) outbreak, DEA, like many federal agencies, has mandated telework for its FOIA staff. As a result, you may experience a delay in receiving a substantive response to your FOIA request. DEA will finish processing your request as quickly as possible at the resolution of the COVID-19 emergency.

Thank you for your patience as we work to complete the processing of your request

Tonia Woodley
IBSS Corp. Paralegal III (Contractor)
Initial Review Team
Freedom of Information/Privacy Act Section (FSR)
U.S. Drug Enforcement Administration
Email: Tonia.Woodley@usdoj.gov<mailto:Tonia.Woodley@usdoj.gov>
Phone: 571-776-3704

PRIVACY ACT NOTICE: This e-mail (including any attachments herein) may contain personal and privileged information that requires protection in compliance with the Privacy Act of 1974 (5 U.S.C. § 552a). Any use of this information by anyone other than the intended recipient is prohibited. If you have received this communication in error, please immediately delete all copies of this information and notify me by e-mail. The use, dissemination, distribution, or reproduction of this communication by unintended recipients in not authorized and may be unlawful.

From: Drug Enforcement Administration

Good afternoon Mr. McElwee,

We are in receipt of your recent inquiry regarding the status of your pending Freedom of Information/Privacy Act request. Please be advised that due to the national emergency concerning the novel coronavirus disease (COVID-19) outbreak, DEA, like many federal agencies, has mandated telework for its FOIA staff. As a result, you may experience a delay in receiving a substantive response to your FOIA request. DEA will finish processing your request as quickly as possible at the resolution of the COVID-19 emergency. There is no exact date to give you in reference to when your request will be processed.

Thank you for your patience as we work to complete the processing of your request

Tonia Woodley
IBSS Corp. Paralegal III (Contractor)
Initial Review Team
Freedom of Information/Privacy Act Section (FSR)
U.S. Drug Enforcement Administration
Email: Tonia.Woodley@usdoj.gov<mailto:Tonia.Woodley@usdoj.gov>
Phone: 571-776-3704

PRIVACY ACT NOTICE: This e-mail (including any attachments herein) may contain personal and privileged information that requires protection in compliance with the Privacy Act of 1974 (5 U.S.C. § 552a). Any use of this information by anyone other than the intended recipient is prohibited. If you have received this communication in error, please immediately delete all copies of this information and notify me by e-mail. The use, dissemination, distribution, or reproduction of this communication by unintended recipients in not authorized and may be unlawful.

From: Drug Enforcement Administration

Good Afternoon Mr. McElwee,

We are in receipt of your recent inquiry regarding the status of your pending Freedom of Information/Privacy Act request. Please be advised that due to the national emergency concerning the novel coronavirus disease (COVID-19) outbreak, DEA, like many federal agencies, has mandated telework for its FOIA staff. As a result, you may experience a delay in receiving a substantive response to your FOIA request. DEA will finish processing your request as quickly as possible at the resolution of the COVID-19 emergency.

Thank you for your patience as we work to complete the processing of your request.
Tonia Woodley
IBSS Corp. Paralegal III (Contractor)
Initial Review Team
Freedom of Information/Privacy Act Section (FSR)
U.S. Drug Enforcement Administration
Email: Tonia.Woodley@usdoj.gov<mailto:Tonia.Woodley@usdoj.gov>
Phone: 571-776-3704

PRIVACY ACT NOTICE: This e-mail (including any attachments herein) may contain personal and privileged information that requires protection in compliance with the Privacy Act of 1974 (5 U.S.C. § 552a). Any use of this information by anyone other than the intended recipient is prohibited. If you have received this communication in error, please immediately delete all copies of this information and notify me by e-mail. The use, dissemination, distribution, or reproduction of this communication by unintended recipients in not authorized and may be unlawful.

From: Drug Enforcement Administration

Good Morning Mr. McElwee,

We are in receipt of your recent inquiry regarding the status of your pending Freedom of Information/Privacy Act request. Please be advised that due to the national emergency concerning the novel coronavirus disease (COVID-19) outbreak, DEA, like many federal agencies, has mandated telework for its FOIA staff. As a result, you may experience a delay in receiving a substantive response to your FOIA request. DEA will finish processing your request as quickly as possible at the resolution of the COVID-19 emergency.
Thank you for your patience as we work to complete the processing of your request.

Tonia Woodley
IBSS Corp. Paralegal III (Contractor)
Initial Review Team
Freedom of Information/Privacy Act Section (FSR)
U.S. Drug Enforcement Administration
Email: Tonia.Woodley@dea.gov<mailto:Tonia.Woodley@dea.gov>
Phone: 571-776-3704

PRIVACY ACT NOTICE: This e-mail (including any attachments herein) may contain personal and privileged information that requires protection in compliance with the Privacy Act of 1974 (5 U.S.C. § 552a). Any use of this information by anyone other than the intended recipient is prohibited. If you have received this communication in error, please immediately delete all copies of this information and notify me by e-mail. The use, dissemination, distribution, or reproduction of this communication by unintended recipients in not authorized and may be unlawful.

From: Drug Enforcement Administration

Good morning Mr. McElwee: Please see the attached response to your Freedom of Information/Privacy Act request 21-00197-F.  If you have any questions, please contact our FOIA Requester Service Center at (571) 776-2300. Sincerely, Yvette D. Davis, Chief Intake Unit
Freedom of Information/Privacy Act Section Drug EnforcementAdministration Telephone: (571)776-2300 E-mail: DEA.FOIA@dea.gov PRIVACY ACT NOTICE: This e-mail (including any attachments herein) may contain personal andprivileged information that requires protection in compliance with the PrivacyAct of 1974 (5 U.S.C. § 552a). Any useof this information by anyone other than the intended recipient is prohibited. If you have received this communication inerror, please immediately delete all copies of this information and notify meby e-mail. The use, dissemination,distribution, or reproduction of this communication by unintended recipients innot authorized and may be unlawful.

From: Drug Enforcement Administration

Good Morning Mr. McElwee,

Please see the attached status letter regarding your request 21-00197-F. Please let me know if you have any questions.

Thank you.

Tonia Woodley
IBSS Corp. Paralegal III (Contractor)
Initial Review Team
Freedom of Information/Privacy Act Section (FSR)
U.S. Drug Enforcement Administration
Email: Tonia.Woodley@dea.gov<mailto:Tonia.Woodley@dea.gov>
Phone: 571-776-3704

PRIVACY ACT NOTICE: This e-mail (including any attachments herein) may contain personal and privileged information that requires protection in compliance with the Privacy Act of 1974 (5 U.S.C. § 552a). Any use of this information by anyone other than the intended recipient is prohibited. If you have received this communication in error, please immediately delete all copies of this information and notify me by e-mail. The use, dissemination, distribution, or reproduction of this communication by unintended recipients in not authorized and may be unlawful.

From: Drug Enforcement Administration

Good afternoon Mr. McElwee

As your request is updated, we will send you notification of any documents that are available to you pertaining to your request. Thus there is no exact timeframe or date to give you in reference to when your request will be completed. As a result, you may experience a delay in receiving a response to your FOIA request since DEA, like many federal agencies, has mandated telework for its FOIA staff.

Thank you for your patience as we work to complete the processing of your request.
Tonia Woodley
IBSS Corp. Paralegal III (Contractor)
Initial Review Team
Freedom of Information/Privacy Act Section (FSR)
U.S. Drug Enforcement Administration
Email: Tonia.Woodley@dea.gov<mailto:Tonia.Woodley@dea.gov>
Phone: 571-776-3704

PRIVACY ACT NOTICE: This e-mail (including any attachments herein) may contain personal and privileged information that requires protection in compliance with the Privacy Act of 1974 (5 U.S.C. § 552a). Any use of this information by anyone other than the intended recipient is prohibited. If you have received this communication in error, please immediately delete all copies of this information and notify me by e-mail. The use, dissemination, distribution, or reproduction of this communication by unintended recipients in not authorized and may be unlawful.

From: Drug Enforcement Administration

Good afternoon,

We are in receipt of your recent inquiry regarding the status of your pending Freedom of Information/Privacy Act request. Please be advised that due to the national emergency concerning the novel coronavirus disease (COVID-19) outbreak, DEA, like many federal agencies, has mandated telework for its FOIA staff. As a result, you may experience a delay in receiving a response to your FOIA request. DEA will finish processing your request as quickly as possible at the resolution of the COVID-19 emergency.

Thank you for your patience as we work to complete the processing of your request.

Tonia Woodley
IBSS Corp. Paralegal III (Contractor)
Initial Review Team
Freedom of Information/Privacy Act Section (FSR)
U.S. Drug Enforcement Administration
Email: Tonia.Woodley@dea.gov<mailto:Tonia.Woodley@dea.gov>
Phone: 571-776-3704

PRIVACY ACT NOTICE: This e-mail (including any attachments herein) may contain personal and privileged information that requires protection in compliance with the Privacy Act of 1974 (5 U.S.C. § 552a). Any use of this information by anyone other than the intended recipient is prohibited. If you have received this communication in error, please immediately delete all copies of this information and notify me by e-mail. The use, dissemination, distribution, or reproduction of this communication by unintended recipients is not authorized and may be unlawful

From: Drug Enforcement Administration

Good afternoon Mr. McElwee,

As your request is updated, we will send you notification of any documents that are available to you pertaining to your request. Thus there is no exact timeframe or date to give you in reference to when your request will be completed. As a result, you may experience a delay in receiving a response to your FOIA request since DEA, like many federal agencies, has mandated telework for its FOIA staff.

Thank you for your patience as we work to complete the processing of your request.

Tonia Woodley
IBSS Corp. Paralegal III (Contractor)
Initial Review Team
Freedom of Information/Privacy Act Section (FSR)
U.S. Drug Enforcement Administration
Email: Tonia.Woodley@dea.gov<mailto:Tonia.Woodley@dea.gov>
Phone: 571-776-3704

PRIVACY ACT NOTICE: This e-mail (including any attachments herein) may contain personal and privileged information that requires protection in compliance with the Privacy Act of 1974 (5 U.S.C. § 552a). Any use of this information by anyone other than the intended recipient is prohibited. If you have received this communication in error, please immediately delete all copies of this information and notify me by e-mail. The use, dissemination, distribution, or reproduction of this communication by unintended recipients is not authorized and may be unlawful

From: Drug Enforcement Administration

Good afternoon,

Your request is in processing and has been assigned to GIS Rhoda Green. If you have any further questions please reach out to her at the cc’d email address above.

Thank you and Happy New Year.

Tonia Woodley
IBSS Corp. Paralegal III (Contractor)
Initake Sub-Unit
Freedom of Information/Privacy Act Section
U.S. Drug Enforcement Administration
Email: Tonia.Woodley@dea.gov<mailto:Tonia.Woodley@dea.gov>
Phone: 571-776-3704

PRIVACY ACT NOTICE: This e-mail (including any attachments herein) may contain personal and privileged information that requires protection in compliance with the Privacy Act of 1974 (5 U.S.C. § 552a). Any use of this information by anyone other than the intended recipient is prohibited. If you have received this communication in error, please immediately delete all copies of this information and notify me by e-mail. The use, dissemination, distribution, or reproduction of this communication by unintended recipients is not authorized and may be unlawful

From: Drug Enforcement Administration

Good Morning Mr. McElwee,

Please reference the attached status letter that was sent via email to you on August 18, 2021.

In the meantime, there is no exact timeframe to provide you with for a response however Ms. Green will update you when something becomes available.

Thank you.

Tonia Woodley
IBSS Corp. Paralegal III (Contractor)
Intake Sub-Unit (CCARN)
Freedom of Information/Privacy Act Unit
U.S. Drug Enforcement Administration
Email: Tonia.Woodley@dea.gov<mailto:Tonia.Woodley@dea.gov>
Phone: 571-776-3704

PRIVACY ACT NOTICE: This e-mail (including any attachments herein) may contain personal and privileged information that requires protection in compliance with the Privacy Act of 1974 (5 U.S.C. § 552a). Any use of this information by anyone other than the intended recipient is prohibited. If you have received this communication in error, please immediately delete all copies of this information and notify me by e-mail. The use, dissemination, distribution, or reproduction of this communication by unintended recipients is not authorized and may be unlawful

From: Drug Enforcement Administration

Good Morning,

Your request 20-00632F is pending review. There is no exact timeframe to give you in regards to when you can expect your records but we are working as quickly as possible.
Thank you.

Tonia Woodley
IBSS Corp. Paralegal III (Contractor)
Intake Sub-Unit (CCARN)
Freedom of Information/Privacy Act Unit
U.S. Drug Enforcement Administration
Email: Tonia.Woodley@dea.gov<mailto:Tonia.Woodley@dea.gov>
Phone: 571-776-3704

PRIVACY ACT NOTICE: This e-mail (including any attachments herein) may contain personal and privileged information that requires protection in compliance with the Privacy Act of 1974 (5 U.S.C. § 552a). Any use of this information by anyone other than the intended recipient is prohibited. If you have received this communication in error, please immediately delete all copies of this information and notify me by e-mail. The use, dissemination, distribution, or reproduction of this communication by unintended recipients is not authorized and may be unlawful

From: Drug Enforcement Administration

Good Morning,

Your request 20-00632F is pending review. There is no exact timeframe to give you in regards to when you can expect your records but we are working as quickly as possible.
Thank you.

Tonia Woodley
IBSS Corp. Paralegal III (Contractor)
Intake Sub-Unit (CCARN)
Freedom of Information/Privacy Act Unit
U.S. Drug Enforcement Administration
Email: Tonia.Woodley@dea.gov<mailto:Tonia.Woodley@dea.gov>
Phone: 571-776-3704

PRIVACY ACT NOTICE: This e-mail (including any attachments herein) may contain personal and privileged information that requires protection in compliance with the Privacy Act of 1974 (5 U.S.C. § 552a). Any use of this information by anyone other than the intended recipient is prohibited. If you have received this communication in error, please immediately delete all copies of this information and notify me by e-mail. The use, dissemination, distribution, or reproduction of this communication by unintended recipients is not authorized and may be unlawful

Files

pages

Close